SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-008773
Filing Date
2017-05-11
Accepted
2017-05-11 16:12:07
Documents
76
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20170331_10q.htm 10-Q 1074547
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10679
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10486
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4355
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4280
  Complete submission text file 0001437749-17-008773.txt   6895400

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20170331.xml EX-101.INS 1554479
7 EXHIBIT 101.SCH nby-20170331.xsd EX-101.SCH 79660
8 EXHIBIT 101.CAL nby-20170331_cal.xml EX-101.CAL 35612
9 EXHIBIT 101.DEF nby-20170331_def.xml EX-101.DEF 495330
10 EXHIBIT 101.LAB nby-20170331_lab.xml EX-101.LAB 422207
11 EXHIBIT 101.PRE nby-20170331_pre.xml EX-101.PRE 517850
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 17834417
SIC: 2834 Pharmaceutical Preparations